Eventide Asset Management - KINNATE BIOPHARMA INC ownership

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 60 filers reported holding KINNATE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of KINNATE BIOPHARMA INC
ValueSharesWeighting
Q4 2020$6,962,000175,0000.11%
Other shareholders
KINNATE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 3,525,957$4,936,3407.88%
Foresite Capital Management IV, LLC 9,671,643$13,540,3007.52%
Vida Ventures Advisors, LLC 2,207,772$3,090,8814.78%
Lynx1 Capital Management LP 1,997,006$2,795,8081.85%
Nextech Invest Ltd. 2,329,480$3,261,2720.99%
Orbimed Advisors 8,009,729$11,213,6210.24%
Novo Holdings A/S 815,707$1,141,9900.08%
DAFNA Capital Management LLC 105,179$147,2510.05%
GSA CAPITAL PARTNERS LLP 374,291$5240.04%
Rock Springs Capital Management LP 405,811$568,1350.02%
View complete list of KINNATE BIOPHARMA INC shareholders